Renalytix Plc RNLX
0.21 USD 0.00 (+0.00%)
At closeOct 7, 2024, 4:00 PM EDT
0.19 Day range 0.225
0.12 52-week range 2.40
- YTD
- 0.00%
- 1 year
- 0.00%
Financial health
Altman Z-Score
-81.21 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.8×
FY 2018 5y median -5.3× FY 2024
P/S 11.9×
FY 2018 5y median 56.1× FY 2024
P/B -3.5×
FY 2018 5y median 13.0× FY 2024
P/FCF -0.9×
FY 2018 5y median -7.3× FY 2024
EV/EBITDA -1.1×
FY 2018 5y median -5.5× FY 2024
EV/Sales 13.5×
FY 2018 5y median 46.4× FY 2024
FCF Yield -111.0%
FY 2018 5y median -13.6% FY 2024
Profitability
Gross Margin 6.8%
FY 2018 5y median 20.6% FY 2024
Operating Margin -1293.5%
FY 2018 5y median -1293.5% FY 2024
Net Margin -1461.6%
FY 2018 5y median -1461.6% FY 2024
ROE 426.0%
FY 2018 5y median -36.5% FY 2024
ROIC -4347.7%
FY 2018 5y median -103.0% FY 2024
ROA -419.7%
FY 2018 5y median -71.6% FY 2024
Growth (YoY)
Revenue -32.7%
FY 2018 FY 2024
Operating Income 30.1%
FY 2018 FY 2024
EPS (diluted) 43.6%
FY 2018 FY 2024
Free Cash Flow 7.8%
FY 2018 FY 2024
Financial Health
Current Ratio 0.5×
FY 2018 5y median 3.9× FY 2024
Quick Ratio 0.5×
FY 2018 5y median 3.8× FY 2024
Debt / Equity -1.1×
FY 2018 5y median 0.0× FY 2024
Net Debt / EBITDA -0.1×
FY 2018 5y median 0.5× FY 2024
Interest Coverage 0.0×
FY 2018 5y median -5539× FY 2024
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2024
Annual · latest fiscal year ends 2024-06-30
